PSA-Screening und molekulare Marker

Prostate-Specific Antigen–Based Screening for Prostate Cancer

(2018) Joshua J. Fenton et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Effect of a Low-Intensity PSA-Based Screening Intervention on Prostate Cancer Mortality

(2018) Richard M. Martin et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Prediction of High-grade Prostate Cancer Following Multiparametric Magnetic Resonance Imaging: Improving the Rotterdam European Randomized Study of Screening for Prostate Cancer Risk Calculators

(2018) Arnout R. Alberts et al.   EUROPEAN UROLOGY

Prostate Needle Biopsy Outcomes in the Era of the U.S. Preventive Services Task Force Recommendation against Prostate Specific Antigen Based Screening

(2016) John S. Banerji et al.   JOURNAL OF UROLOGY

A Multi-institutional Prospective Trial in the USA Confirms that the 4Kscore Accurately Identifies Men with High-grade Prostate Cancer

(2015) Dipen J. Parekh et al.   EUROPEAN UROLOGY

National Prostate Cancer Screening Rates After the 2012 US Preventive Services Task Force Recommendation Discouraging Prostate-Specific Antigen–Based Screening

(2015) Michael W. Drazer et al.   JOURNAL OF CLINICAL ONCOLOGY

The Prostate Health Index Selectively Identifies Clinically Significant Prostate Cancer

(2015) Stacy Loeb et al.   JOURNAL OF UROLOGY

Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up

(2014) Fritz H Schröder et al.   LANCET

Mortality and complications after prostate biopsy in the Prostate, Lung, Colorectal and Ovarian Cancer Screening (PLCO) trial

(2013) Paul F. Pinsky et al.   BJU INTERNATIONAL

Prospective Randomized Evaluation of Risk-adapted Prostate-specific Antigen Screening in Young Men: The PROBASE Trial

(2013) Christian Arsov et al.   EUROPEAN UROLOGY

Strategy for detection of prostate cancer based on relation between prostate specific antigen at age 40-55 and long term risk of metastasis: case-control study

(2013) A. J. Vickers et al.   BMJ-British Medical Journal

Screening for Prostate Cancer Decreases the Risk of Developing Metastatic Disease: Findings from the European Randomized Study of Screening for Prostate Cancer (ERSPC)

(2012) Fritz H. Schröder et al.   EUROPEAN UROLOGY

Prostate Cancer Screening in the Randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: Mortality Results after 13 Years of Follow-up

(2012) G. L. Andriole et al.   JNCI-Journal of the National Cancer Institute

A Multicenter Study of [-2]Pro-Prostate Specific Antigen Combined With Prostate Specific Antigen and Free Prostate Specific Antigen for Prostate Cancer Detection in the 2.0 to 10.0 ng/ml Prostate Specific Antigen Range

(2011) William J. Catalona et al.   JOURNAL OF UROLOGY

Assessing contamination and compliance in the prostate component of the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial

(2010) Paul F Pinsky et al.   Clinical Trials

A Risk-Based Strategy Improves Prostate-Specific Antigen–Driven Detection of Prostate Cancer

(2009) Monique J. Roobol et al.   EUROPEAN UROLOGY

Screening and Prostate-Cancer Mortality in a Randomized European Study

(2009) Fritz H. Schröder et al.   NEW ENGLAND JOURNAL OF MEDICINE

A panel of kallikrein markers can reduce unnecessary biopsy for prostate cancer: data from the European Randomized Study of Prostate Cancer Screening in Göteborg, Sweden

(2008) Andrew J Vickers et al.   BMC Medicine